LOOKS LIKE PHARMACYTE BIOTECH ACQUIRING THE WORLD WIDE RIGHTS TO CELL IN A BOX WAS ON THE RIGHT TRACK ALL ALONG
LOOKS LIKE CELL IN A BOX HAS BEEN ON THE RIGHT TRACK ALL ALONG
Prof. Hans-Peter Hammes, M.D.
“I am very much looking forward to contribute to this exciting field on which so many patients with type 1 diabetes put a lot of hope. Since the early days of clinical training by Konrad Federlin, islet replacement therapy was on the agenda, and the prevention of diabetic microvascular complications by islet transplantation was among my earliest experimental studies.”
but then that is why us longs bought in the first place...we were able to vision what the right track was...
bull
News 
Market Data 
Discover 
